Clinical efficiency of restorative treatment after percutaneous coronary intervention in patients with coronary artery disease

Nodir Kayumov  Ulug’bekovich; Djamshid Payziev  Djuravaevich; Orziev Daler  Zavkiddinovich

doi:10.30574/gscbps.2021.17.1.0311

Authors

Nodir Kayumov Ulug’bekovich Department of Internal Medicine, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan.
Djamshid Payziev Djuravaevich Department of Cardiology, Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, UZBEKISTAN.
Orziev Daler Zavkiddinovich Department of Cardiology, Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, UZBEKISTAN.

DOI:

https://doi.org/10.30574/gscbps.2021.17.1.0311

Keywords:

Ischemic heart disease, Stable angina pectoris, Stenting of coronary arteries, Cardiac rehabilitation, Statins, Antiplatelet agents

Abstract

The article discusses topical issues of treatment and rehabilitation strategies in patients with ischemic heart disease (IHD). The results of our own research on assessing the effectiveness of complex rehabilitation of patients with myocardial changes with the study of indicators of lipid metabolism, platelet aggregation, functional state of patients with coronary artery disease, after stenting of the coronary arteries have been stated in the article.

Metrics

Metrics Loading ...

References

Alyavi A, Uzokov J. Treatment of stable angina pectoris: focus on the role of calcium antagonists and ACE inhibitors. Ontario Health Technology Assessment Series. 2017; 15(9): 1-12.

Alyavi B, Uzokov J. Peripheral artery disease in the lower extremities: indications for treatment. E-journal of Cardiology Practice. 2018; 16(9): 1-10.

Lyutfullayevich AA, Karimovna TD, Talgatovna SZ, Iskandarovna RD, Kamilovich UJ, Davlatovich SJ, Berkzod T. Relationship between hemodynamic parametres and nppa, nppb, npr3 genes polymorphism in patients with ischemic heart disease. International scientific review. 2017; 7(38); 50-56.

Mukhamedova M, Alyavi BA, Uzokov JK, Babaev MA, Kamilova SE. P120 Relationship between left ventricular global function index and cardiac systolic functions in patients with chronic ischemic disease of the heart and diabetes mellitus. European Heart Journal-Cardiovascular Imaging. 2019; 20(Supplement_3): jez147-008.

Uzokov J, Alyavi A, Alyavi B. Influence of combination therapy of rosuvastatin and telmisartan on vascular and metabolic profile in hypercholesterolemic patients with metabolic syndrome. Atherosclerosis. 2017; 263: e241.

Ahmedov I, Mirzaev T, Uzokov J, Jurakulov N. Features of hyperreninemic aldosteronism in hypertension patients with metabolic syndrome: 87. European Journal of Preventive Cardiology. 2016; 23(1).

Iskhakov S, Uzokov J, Kamilova S. Comparative analysis of the inflammatory biomarkers in patients with stable coronary artery disease and metabolic syndrome. Atherosclerosis. 2019; 287: e171.

Usarov M, Mamatkulov X, Uzokov J, Hojiev S, Yakhshilikov D, Dadaev S. Ps 11-56 Efficacy Of Combination Therapy Using Nebivalol And Trimetazidine In Hypertensive Patients With Metabolic Syndrome And Stable Angina. Journal of Hypertension. 2016; 34: e349.

IR Agababyan, SS Soleeva, MG Mukhemedova, J Uzokov. Condition of coronary arteries and change of lipid profile in coronary heart disease. Journal of Critical Reviews. 7(19): 4719-4723.

Babaev M, Alyavi AL, Alyavi BA, Uzokov JK. P2533 Influence of l-arginine aspartate on vascular markers in hypertensive patients with metabolic syndrome. European Heart Journal. 2018; 39(suppl_1): ehy565-P2533.

Chong J, Bulluck H, Fw Ho A, Boisvert WA, Hausenloy DJ. Chronic remote ischemic conditioning for cardiovascular protection. Conditioning medicine. 2019; 2(4): 164–169.

Lutfullayevich AA, Anisxonovich AB, Kamilovich UJ, Ismatovich AS, Ulugbekovich KN. GW28-e0699 Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome. Journal of the American College of Cardiology. 2017; 70(16S): C138-C139.

Alyavi AL, Alyavi BA, Tulyaganova DK, Aliahunova MY, Sabirzhanova ZT, Nuritdinova SK, Sayfiev NY. Features of Inflammatory Markers in Patients With Coronary Heart Disease. International Journal of Healthcare and Medical Sciences. 2018; 4(10): 188-192.

Alyavi B, Alyavi A, Uzokov J. Role of pro-inflammatory cytokines in metabolic syndrome. ALLERGY. 2018; 73: 562-562.

Alyavi AL, Alyavi BA, Tulyaganova DK, Aliahunova MY, Sabirzhanova ZT, Nuritdinova SK, Sayfiev NY. Features of Inflammatory Markers in Patients With Coronary Heart Disease. International Journal of Healthcare and Medical Sciences. 2018; 4(10): 188-192.

Uzokov J. Influence of abnormal lipid components in statin-naive young adults: Is there any gap?. European journal of preventive cardiology. 2020; 27(8): 868–869.

Lutfullayevich AA, Anisxonovich AB, Kamilovich UJ, Ismatovich AS, Ulugbekovich KNGW28-e0698 Telmisartan with amlodipine versus lisinopril with amlodipine on home blood pressure variability in patients with metabolic syndrome. Journal of the American College of Cardiology. 2017; 70(16S): C138-C138.

Uzokov J, Alyavi A, Alyavi B, Azizov S. Influence of Combined Therapy on Inflammatory State and Pro-inflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome. European Cardiology Review. 2020; 15.

Gafurjanovna MM, Saidjanovna ND, Jamol U. Efficacy of rosuvastatin on lipid parameters and vascular and inflammatory markers in patients with metabolic syndrome and coronary artery disease. Journal of critical reviews. 2020; 7(19): 8112-8115.

Bekbaulieva GN, Abduraimova GA, Razzakova NS, Uzokov J. Influence of technologies of effective perinatal care on operating indicators of obstetric complexes. Journal of Critical Reviews. 2020; 7(9): 1182-1184.

Uzokov J, Alyavi B, Payziev D. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease. Atherosclerosis. 2020; 315: e253.

Uzokov J, Alyavi B. Combination lipid lowering therapy with rosuvastatin and ezetimibe in dyslipidemic patients with stable coronary artery disease and metabolic syndrome. Atherosclerosis. 2018; 275: e231.

Alyavi A, Alyavi B, Uzokov J, Payziev D. Influence of Diet with Low Glycemic Index on Lipid Spectrum in Patients with Ischemic Disease of the Heart. Atherosclerosis Supplements. 2018; 32: 158.

Matić I, Froelicher ES, Uzokov J, Ljubas A. A Survey on Cardiovascular Nursing Occupational Standard: Meeting the Needs of Employers. Policy, Politics, & Nursing Practice. 2021; 22(1): 73-79.